Carboxyamidotriazole orotate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCarboxyamidotriazole orotate

Drug Alias NameCAI orotateCTOPravitinibL-651582 orotate

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor inhibitors

TargetsVascular endothelial growth factor

Therapy Area/IndicationsSkin MelanomaCNS Embryonal TumorSolid tumours +[15]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPuerto RicoSouth Africa

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Active IndicationsSolid tumoursGlioblastomaGlioma

Inactive IndicationsSkin MelanomaCNS Embryonal TumorKidney Neoplasms +[12]

ATC CodeN/A